Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)

Details for Australian Patent Application No. 2006321321 (hide)

Owner BioVendor Laboratory Medicine, Inc.

Inventors Ruzicka, Viktor

Agent Lord and Company

Pub. Number AU-B-2006321321

PCT Pub. Number WO2007/063363

Priority 10 2005 034 788.6 21.07.05 DE

Filing date 21 July 2006

Wipo publication date 7 June 2007

Acceptance publication date 28 July 2011

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/063363 Priority application(s): WO2007/063363

28 July 2011 Application Accepted

  Published as AU-B-2006321321

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006321323-Ophthalmic lens

2006321294-Pharmaceutical compositions comprising carboxyalkylsulfonic acids